Skip to main content

Table 4 Plasma levels of inflammatory cytokines

From: Anti-inflammatory and antioxidant efficacy of lavender oil in experimentally induced thrombosis

Group

TNF-α, pg/mL

RANTES, pg/mL

MCP-1, ng/mL

C

39.07 [37.57 to 41.3]

{34.38 to 45.42}

923.45 [848.06 to 970.8]

{724.55 to 1085.3}

1.05 [0.91 to 1.19]

{0.85 to 1.3}

T

61.68 [56.53 to 65.2]

{53.99 to 76.35}

1000.2 [958.35 to 1098.6]

{817.2 to 1263.8}

1.85 [1.56 to 1.97]

{1.3 to 2.1}

TPOLO

59.18 [57.6 to 62.26]

{56.5 to 67.77}

974.05 [876.96 to 1177.65]

{815.5 to 1294.9}

1.45 [1.4 to 1.5]

{1.35 to 1.6}

TSCLO

52.67 [50.74 to 57.81]

{48.77 to 63.35}

952.2 [881.88 to 1015.81]

{832.75 to 1223}

1.53 [1.46 to 1.64]

{1.2 to 1.75}

TIPLO

50.46 [43.15 to 53.78]

{39.77 to 55.91}

690.18 [627.01 to 762.75]

{552.95 to 835.85}

1.25 [1.2 to 1.3]

{1.1 to 1.35}

Stat. (p-value)

35.7 (< 0.0001)

23.8 (0.0001)

36.6 (< 0.0001)

  1. Data are summarized as median [Q1 to Q3] and {min to max}, where Q1 is the 25th percentile, Q3 is the 75th percentile, min is the minimum and max is the maximum value. C = Control group; T = Thrombosis group; TPOLO = Lavender oil Per Os group; TSCLO = SubCu-taneously Lavender Oil group; TIPLO = IntraPeritoneal Lavender Oil group;  Stat. = the statistics of the Kruskal-Wallis test